Interruption des thérapies ciblées en cas de geste invasif

<table><tbody><tr><th style="text-align: center;" colspan="3"><strong>D&eacute;lai sugg&eacute;r&eacute; d'interruption des th&eacute;rapie cibl&eacute;es AVANT un geste invasif programm&eacute;</strong></th></tr><tr><td style="background-color: #bef2d3; text-align: center;" colspan="3"><strong>Endoscopies digestives, bronchiques ou urinaires</strong></td></tr><tr><td style="text-align: left;" colspan="3">Pas de suspension des th&eacute;rapies cibl&eacute;es, m&ecirc;me en cas de biopsie.</td></tr><tr><td style="background-color: #bef2d3; text-align: center;">&nbsp;</td><td style="background-color: #bef2d3; text-align: center;"><p><strong>Chirurgie &agrave; faible risque<br /></strong><span style="font-weight: 400;">(orthop&eacute;dique dont PTG/PTH, ophtalmologique, dermatologique, biopsies mammaires, acte invasif dentaire* + Tatouage)</span></p></td><td style="background-color: #bef2d3; text-align: center;"><p><strong>Piercing ou Chirurgie en milieu non st&eacute;rile<br /></strong><span style="font-weight: 400;">(digestive, uro-g&eacute;nitale, thoracique, t&ecirc;te et cou, chirurgie de foyer infectieux)</span></p></td></tr><tr><td style="text-align: center;"><p><strong>ADALIMUMAB</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">3 semaines</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">6 - 10 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>CERTOLIZUMAB</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">3 semaines (5 semaines si 400mg)</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">6 - 10 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>ETANERCEPT</strong></p></td><td style="text-align: center;" colspan="2"><p><span style="font-weight: 400;">2 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>GOLIMUMAB</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">5 semaines</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">6 - 10 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>INFLIXIMAB IV</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">9 semaines</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">4 - 8 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>INFLIXIMAB SC</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">3 semaines</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">5 - 10 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>TOCILIZUMAB IV</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">5 semaines</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">9 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>TOCILIZUMAB SC</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">2 semaines</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">5 - 9 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>SARILUMAB SC</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">3 semaines</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">9 - 15 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>ABATACEPT&nbsp; IV</strong></p></td><td style="text-align: center;" colspan="2"><p><span style="font-weight: 400;">2 - 4 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>ABATACEPT SC</strong></p></td><td style="text-align: center;" colspan="2"><p><span style="font-weight: 400;">2 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>BARICITINIB</strong></p></td><td style="text-align: center;" colspan="2"><p><span style="font-weight: 400;">1 semaine</span></p></td></tr><tr><td style="text-align: center;"><p><strong>TOFACITINIB</strong></p></td><td style="text-align: center;" colspan="2"><p><span style="font-weight: 400;">1 semaine</span></p></td></tr><tr><td style="text-align: center;"><p><strong>RITUXIMAB IV</strong></p></td><td style="text-align: center;" colspan="2"><p><span style="font-weight: 400;">6 mois (id&eacute;alement, sinon 5 mois)</span></p></td></tr><tr><td style="text-align: center;"><p><strong>BELIMUMAB IV</strong></p></td><td style="text-align: center;" colspan="2"><p><span style="font-weight: 400;">14 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>USTEKINUMAB</strong></p></td><td style="text-align: center;" colspan="2"><p><span style="font-weight: 400;">15 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>SECUKINUMAB<br />(IL-17)</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">5 semaines</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">12 - 19 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>IXEKIZUMAB<br />(IL-17)</strong></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">5 semaines</span></p></td><td style="text-align: center;"><p><span style="font-weight: 400;">6 - 9 semaines</span></p></td></tr><tr><td style="text-align: center;"><p><strong>ANAKINRA<br />(IL-1)</strong></p></td><td style="text-align: center;" colspan="2"><p><span style="font-weight: 400;">1 semaine</span></p></td></tr><tr><td style="text-align: left;" colspan="3">*Interruption non n&eacute;cessaire pour les interventions suivantes : d&eacute;tartrage / acte de pr&eacute;vention non sanglant / soins conservateurs / pose ou ajustement d'appareils orthodontiques ou de proth&egrave;ses amovibles / soins proth&eacute;tiques non sanglants / d&eacute;pose de sutures...</td></tr></tbody></table><p>La reprise du traitement par th&eacute;rapie cibl&eacute;e pourra &ecirc;tre envisag&eacute;e apr&egrave;s cicatrisation.</p><p>D'apr&egrave;s <a href="https://www.ordotype.fr/liens-utiles/club-rhumatismes-et-inflammations-cri" target="_blank" rel="noopener">Club Rhumatismes et Inflammations</a>&nbsp;(novembre 2020). Pour plus de d&eacute;tails, visitez <strong><a href="https://www.ordotype.fr/liens-utiles/que-faire-en-cas-de-chirurgie-de-soins-dentaires-ou-de-brulures" target="_blank" rel="noopener">ce lien</a></strong>.</p>